Multimeric-001 Universal Flu Vaccine: Phase II data

The double-blind, Israeli Phase II BVX-005 trial in 120 elderly volunteers aged 65 and older showed that 2 doses of 500 µg Multimeric-001 Universal Flu Vaccine given 21 days apart were safe and well t...